Observational analysis revealed hematological changes in platelets for predicting preeclampsia in women, highlighting the need for effective monitoring.
Key Points
Preeclampsia monitoring could prevent 1 in 3 maternal deaths in Yemen, significantly improving maternal health.
Preeclamptic patients showed lower platelet counts and higher mean platelet volume, suggesting platelet consumption and activation.
Platelet indices, including thrombocytopenia and increased mean platelet volume, could serve as early low-cost indicators in resource-limited settings.
The findings support the need for improved screening tools for preeclampsia to reduce maternal and fetal morbidity.